The consolidated results from the experiments reported here will lead to a deeper understanding of the GDNF-RET signaling mechanism and have the potential to aid in the development of novel therapies, the repurposing of current therapies, and the identification of biomarkers for the treatment of endocrine resistant breast cancer. Here, GDNF is linked to breast cancer.